Media Coverage Oligomerix Awarded a $3.19 Million Grant from NIA BioWorld September 15, 2020 By vera This article is sourced from an external publication. Read the original → ← PreviousOligomerix Receives $3.19 Million NIH Commercialization Readiness Pilot Grant for Alzheimer’s Disease TherapyNext →Oligomerix Relocates Headquarters to Accommodate Growth
